Stephanie L. Hines

Observed frequency and challenges of variant reclassification in a hereditary cancer clinic

Sarah Macklin, Nisha Durand, Paldeep S. Atwal et al. · Genetics in Medicine · 2017 · 102 citations · Full text

Oncology, Somatic Variant, Tumor Heterogeneity +9

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

Stephanie L. Hines, Betty A. Mincey, Todor Dentchev et al. · Breast Cancer Research and Treatment · 2009 · 85 citations · Full text

Bone Disease, Zoledronic Acid, Bone Loss +10

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

Stephanie L. Hines, Betty A. Mincey, Jeff A. Sloan et al. · Journal of Clinical Oncology · 2008 · 85 citations · Full text

Physician interpretation of variants of uncertain significance

Sarah Macklin, Jessica L. Jackson, Paldeep S. Atwal et al. · Familial Cancer · 2018 · 77 citations

Differential Diagnosis, Diagnosis, Physician Interpretation +3

Ductal Carcinoma In Situ of the Breast

Richard J. Lee, Laura A. Vallow, Sarah A. McLaughlin et al. · International Journal of Surgical Oncology · 2012 · 47 citations · Full text

Surgical Oncology, Breast Oncology, Radiation Therapy +14